Skip to main content
Article

Frequency of mutations in “thrombophilic state” genes in Uzbekistan

Sh. E. SadikovaScientific Research Institute of Hematology and Blood Transfusion, Ministry of Health of the Republic of Uzbekistan, Tashkent, UzbekistanKh. Ya. KarimovScientific Research Institute of Hematology and Blood Transfusion, Ministry of Health of the Republic of Uzbekistan, Tashkent, UzbekistanШ. М. МуминовScientific Research Institute of Hematology and Blood Transfusion, Ministry of Health of the Republic of Uzbekistan, Tashkent, UzbekistanR. P. TulakovScientific Research Institute of Hematology and Blood Transfusion, Ministry of Health of the Republic of Uzbekistan, Tashkent, UzbekistanК Т БобоевScientific Research Institute of Hematology and Blood Transfusion, Ministry of Health of the Republic of Uzbekistan, Tashkent, Uzbekistan
Cytology and Geneticsjournal2008en
ABI

Abstract

The frequency of mutations in a number of genetic markers, specifically factor V gene (G1691A), blood coagulation factor II gene (G20210A), and the methylenetetrahydrofolate reductase (MTHFR) gene (C677T), is studied in ethnic Uzbek patients with deep vein thrombosis of the lower extremities and in healthy donors. It is established that the incidence of mutant alleles among patients in Uzbekistan for FV Leiden is 12.9%; for prothrombin, 4%; and for MTHFR, 47.8%. The mutant allele C677T of the MTHFR gene has the highest expressivity in the appearance of MTHFR (47.8%). It is noted that this mutation in the MTHFR gene is encountered significantly more frequently in females with deep vein thrombosis than in males with deep vein thrombosis. The G20210A mutation in the prothrombin gene is encountered more rarely in the Uzbek population. The penetrance is studied and the role of these mutations in the appearance of deep vein thrombosis is estimated.

Topics

Identifiers

Citations and references